Violation
Patients who are positive for the interleukin-1 (IL-1)
are at increased risk for severe periodontal disease.
have a decreased inflammatory response in the presence of bacteria.
are more likely to respond favourably to periodontal therapy.
have decreased bacterial pathogens associated with active periodontal disease.